Alpha Lipoic Acid, Arnica Montanaroot,sus Scrofa Cartilage,coenzyme A, Solanum Dulcamara Top, Sus Scrofa Embryo,sus Scrofa Umbilical Cord,nadide,sodium Diethyl Oxalacetate, Sus Scrofa Placenta,toxicodendron Pubescens Leaf,sanguinaria Canadensis Root,silicon Dioxide,sulfur,comfrey Root Tablet
NDC Package 51885-9494-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Alpha Lipoic Acid, Arnica Montanaroot, Sus Scrofa Cartilage, Coenzyme A, Solanum Dulcamara Top, Sus Scrofa Embryo, Sus Scrofa Umbilical Cord, Nadide, Sodium Diethyl Oxalacetate, Sus Scrofa Placenta, Toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Silicon Dioxide, Sulfur, Comfrey Root tablets is a drug for further processing. This formulation utilizes a tablet delivery system. Marketed by Biologische Heilmittel Heel, this product is identified by NDC 51885-9494.

Identification & Billing

NDC Package Code
51885-9494-2
Package Description
1 BAG in 1 BOX / 1 TABLET in 1 BAG
Product Code
51885-9494
11-Digit Billing Format
51885949402

Clinical Specifications

Proprietary Name
Alpha Lipoic Acid, Arnica Montanaroot, Sus Scrofa Cartilage, Coenzyme A, Solanum Dulcamara Top, Sus Scrofa Embryo, Sus Scrofa Umbilical Cord, Nadide, Sodium Diethyl Oxalacetate, Sus Scrofa Placenta, Toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Silicon Dioxide, Sulfur, Comfrey Root
Non-Proprietary Name
Alpha Lipoic Acid, Arnica Montanaroot, Sus Scrofa Cartilage, Coenzyme A, Solanum Dulcamara Top, Sus Scrofa Embryo, Sus Scrofa Umbilical Cord, Nadide, Sodium Diethyl Oxalacetate, Sus Scrofa Placenta, Toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Silicon Dioxide, Sulfur, Comfrey Root
Substance Name
Alpha Lipoic Acid; Arnica Montana Root; Coenzyme A; Comfrey Root; Nadide; Sanguinaria Canadensis Root; Silicon Dioxide; Sodium Diethyl Oxalacetate; Solanum Dulcamara Top; Sulfur; Sus Scrofa Cartilage; Sus Scrofa Embryo; Sus Scrofa Placenta; Sus Scrofa Umbilical Cord; Toxicodendron Pubescens Leaf
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Biologische Heilmittel Heel
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
09-10-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51885-9494-2 identifies a specific commercial package of 1 bag in 1 box / 1 tablet in 1 bag of Alpha Lipoic Acid, Arnica Montanaroot, Sus Scrofa Cartilage, Coenzyme A, Solanum Dulcamara Top, Sus Scrofa Embryo, Sus Scrofa Umbilical Cord, Nadide, Sodium Diethyl Oxalacetate, Sus Scrofa Placenta, Toxicodendron Pubescens Leaf, Sanguinaria Canadensis Root, Silicon Dioxide, Sulfur, Comfrey Root (UNFINISHED drug), drug for further processing labeled by Biologische Heilmittel Heel. This tablet is formulated for use and contains alpha lipoic acid; arnica montana root; coenzyme a; comfrey root; nadide; sanguinaria canadensis root; silicon dioxide; sodium diethyl oxalacetate; solanum dulcamara top; sulfur; sus scrofa cartilage; sus scrofa embryo; sus scrofa placenta; sus scrofa umbilical cord; toxicodendron pubescens leaf as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biologische Heilmittel Heel on September 10, 2021. The current certification is valid through December 31, 2026.

How is this Biologische Heilmittel Heel product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51885949402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51885-9494-2
11-Digit CMS (5-4-2)
51885-9494-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.